Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4832347 | 5918267 | F | 1 | 4832347-9 | 20050101 | 20051108 | 20051117 | EXP | USA0510110604 | ELI LILLY AND COMPANY | 41 | YR | M | N | 80 | KG | 20051110 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4832347 | 1006642220 | PS | FORTEO | 1 | 20 UG DAY | D | 21318 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4832347 | 1006642220 | OSTEOPOROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4832347 | HO |
| 4832347 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4832347 | CONDITION AGGRAVATED |
| 4832347 | HYPERCALCIURIA |
| 4832347 | NEPHROLITHIASIS |
| 4832347 | OSTEONECROSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4832347 | CR |
| 4832347 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4832347 | 1006642220 | 20050101 |